[1]. [1]Sipe JD, Cohen AS. Review: history of the amyloid fibril. J. Struct. Biol. 2000;130:88–98. MEDLINE |
CrossRef
[2]. [2]Westermark GT, Johnson KH, Westermark P. Staining methods for identification of amyloid in tissue. Meth. Enzymol. 1999;309:3–25.
[3]. [3]Astbury WT, Dickinson S, Bailey K. CCLXXIX. The X-ray interpretation of denaturation and the structure of the seed globulins. Biochem. J. 1935;29:2351–2360. MEDLINE
[4]. [4]Sunde M, Blake C. The structure of amyloid fibrils by electron microscopy and X-ray diffraction. Adv. Protein. Chem. 1997;50:123–159. MEDLINE |
CrossRef
[5]. [5]Sunde M, Serpell LC, Bartlam M, Fraser PE, Pepys MB, Blake CC. Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J. Mol. Biol. 1997;273:729–739. MEDLINE |
CrossRef
[6]. [6]LeVine H. Quantification of β-sheet amyloid fibril structures with thioflavin T. Meth. Enzymol. 1999;309:274–284.
[7]. [7]Fradinger EA, Maji SK, Lazo ND, Teplow DB. Studying amyloid beta-protein assembly. In: Xu WXaH editors. Amyloid Precursor Protein. Boca Ration, London, New York, Washington, DC: CRC Press; 2005;p. 83–110.
[8]. [8]Zhang R, Hu X, Khant H, Ludtke SJ, Chiu W, Schmid MF, et al. Interprotofilament interactions between Alzheimer’s Abeta1–42 peptides in amyloid fibrils revealed by cryoEM. Proc. Natl. Acad. Sci. USA. 2009;106:4653–4658.
CrossRef
[9]. [9]Luhrs T, Ritter C, Adrian M, Riek-Loher D, Bohrmann B, Dobeli H, et al. 3D structure of Alzheimer’s amyloid-beta(1–42) fibrils. Proc. Natl. Acad. Sci. USA. 2005;102:17342–17347. MEDLINE |
CrossRef
[10]. [10]Vilar M, Chou HT, Lührs T, Maji SK, Riek-Loher D, Verel R, et al. The fold of alpha-synuclein fibrils. Proc. Natl. Acad. Sci. USA. 2008;105:8637–8642.
CrossRef
[11]. [11]Margittai M, Langen R. Fibrils with parallel in-register structure constitute a major class of amyloid fibrils: molecular insights from electron paramagnetic resonance spectroscopy. Q. Rev. Biophys. 2008;41:265–297.
CrossRef
[12]. [12]Kheterpal I, Cook KD, Wetzel R. Hydrogen/deuterium exchange mass spectrometry analysis of protein aggregates. Meth. Enzymol. 2006;413:140–166.
[13]. [13]Hoshino M, Katou H, Hagihara Y, Hasegawa K, Naiki H, Goto Y. Mapping the core of the beta(2)-microglobulin amyloid fibril by H/D exchange. Nat. Struct. Biol. 2002;9:332–336. MEDLINE |
CrossRef
[14]. [14]Ritter C, Maddelein ML, Siemer AB, Luhrs T, Ernst M, Meier BH, et al. Correlation of structural elements and infectivity of the HET-s prion. Nature. 2005;435:844–848.
CrossRef
[15]. [15]Toyama BH, Kelly MJ, Gross JD, Weissman JS. The structural basis of yeast prion strain variants. Nature. 2007;449:233–237.
CrossRef
[16]. [16]Lansbury PT, Costa PR, Griffiths JM, Simon EJ, Auger M, Halverson KJ, et al Structural model for the β-amyloid fibril based on interstrand alignment of an antiparallel β-sheet comprising a C-terminal peptide. Nat. Struct. Biol. 1995;2:990–998. MEDLINE |
CrossRef
[17]. [17]Balbach JJ, Ishii Y, Antzutkin ON, Leapman RD, Rizzo NW, Dyda F, et al. Amyloid fibril formation by Ab(16–22), a seven-residue fragment of the Alzheimer’s b-amyloid peptide, and structural characterization by solid state NMR. Biochemistry. 2000;39:13748–13759.
[18]. [18]Benzinger TLS, Gregory DM, Burkoth TS, Millerauer H, Lynn DG, Botto RE, et al. Propagating structure of Alzheimers β-amyloid((10–35)) is parallel β-sheet with residues in exact register. Proc. Natl. Acad. Sci. USA. 1998;95:13407–13412. MEDLINE |
CrossRef
[19]. [19]Benzinger TLS, Gregory DM, Burkoth TS, Miller-Auer H, Lynn DG, Botto RE, et al. Two-dimensional structure of b-amyloid (10–35) fibrils. Biochemistry. 2000;39:3491–3499.
[20]. [20]Petkova AT, Ishii Y, Balbach JJ, Antzutkin ON, Leapman RD, Delaglio F, et al. A structural model for Alzheimer’s β-amyloid fibrils based on experimental constraints from solid state NMR. Proc. Natl. Acad. Sci. USA. 2002;99:16742–16747. MEDLINE |
CrossRef
[21]. [21]Nelson R, Sawaya MR, Balbirnie M, Madsen AO, Riekel C, Grothe R, et al. Structure of the cross-beta spine of amyloid-like fibrils. Nature. 2005;435:773–778.
CrossRef
[22]. [22]Sawaya MR, Sambashivan S, Nelson R, Ivanova MI, Sievers SA, Apostol MI, et al. Atomic structures of amyloid cross-beta spines reveal varied steric zippers. Nature. 2007;447:453–457.
CrossRef
[23]. [23]Paravastu AK, Leapman RD, Yau WM, Tycko R. Molecular structural basis for polymorphism in Alzheimer’s beta-amyloid fibrils. Proc. Natl. Acad. Sci. USA. 2008;105:18349–18354.
CrossRef
[24]. [24]Petkova AT, Leapman RD, Guo Z, Yau WM, Mattson MP, Tycko R. Self-propagating, molecular-level polymorphism in Alzheimer’s beta-amyloid fibrils. Science. 2005;307:262–265.
CrossRef
[25]. [25]Meinhardt J, Sachse C, Hortschansky P, Grigorieff N, Fändrich M. Abeta(1–40) fibril polymorphism implies diverse interaction patterns in amyloid fibrils. J. Mol. Biol. 2009;386:869–877.
CrossRef
[26]. [26]Tanaka M, Chien P, Yonekura K, Weissman JS. Mechanism of cross-species prion transmission: an infectious conformation compatible with two highly divergent yeast prion proteins. Cell. 2005;121:49–62. MEDLINE |
CrossRef
[27]. [27]Wasmer C, Lange A, Van Melckebeke H, Siemer AB, Riek R, Meier BH. Amyloid fibrils of the HET-s(218–289) prion form a beta solenoid with a triangular hydrophobic core. Science. 2008;319:1523–1526.
CrossRef
[28]. [28]Steinbacher S, Baxa U, Miller S, Weintraub A, Seckler R, Huber R. Crystal structure of phage P22 tailspike protein complexed with Salmonella sp. O-antigen receptors. Proc. Natl. Acad. Sci. USA. 1996;93:10584–10588. MEDLINE |
CrossRef
[29]. [29]Clantin B, Hodak H, Willery E, Locht C, Jacob-Dubuisson F, Villeret V. The crystal structure of filamentous hemagglutinin secretion domain and its implications for the two-partner secretion pathway. Proc. Natl. Acad. Sci. USA. 2004;101:6194–6199. MEDLINE |
CrossRef
[30]. [30]Maddelein ML, Dos Reis S, Duvezin-Caubet S, Coulary-Salin B, Saupe SJ. Amyloid aggregates of the HET-s prion protein are infectious. Proc. Natl. Acad. Sci. USA. 2002;99:7402–7407. MEDLINE |
CrossRef
[31]. [31]Sokolov Y, Kozak JA, Kayed R, Chanturiya A, Glabe C, Hall JE. Soluble amyloid oligomers increase bilayer conductance by altering dielectric structure. J. Gen. Physiol. 2006;128:637–647. MEDLINE |
CrossRef
[32]. [32]Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science. 1982;216:136–144. MEDLINE
[33]. [33]Krishnan R, Lindquist SL. Structural insights into a yeast prion illuminate nucleation and strain diversity. Nature. 2005;435:765–772.
CrossRef
[34]. [34]Fowler DM, Koulov AV, Alory-Jost C, Marks MS, Balch WE, Kelly JW. Functional amyloid formation within mammalian tissue. PLoS Biol. 2006;4:e6.
CrossRef
[35]. [35]Fowler DM, Koulov AV, Balch WE, Kelly JW. Functional amyloid–from bacteria to humans. Trends Biochem. Sci. 2007;32:217–224. MEDLINE |
CrossRef
[36]. [36]Barnhart MM, Chapman MR. Curli biogenesis and function. Annu. Rev. Microbiol. 2006;60:131–147. MEDLINE |
CrossRef
[37]. [37]Chiti F, Dobson CM. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 2006;75:333–366. MEDLINE |
CrossRef
[38]. [38]Iconomidou VA, Vriend G, Hamodrakas SJ. Amyloids protect the silkmoth oocyte and embryo. FEBS Lett. 2000;479:141–145. Abstract | Full Text |
Full-Text PDF (405 KB)
|
CrossRef
[39]. [39]Osherovich LZ, Weissman JS. The utility of prions. Dev. Cell. 2002;2:143–151. MEDLINE |
CrossRef
[40]. [40]Maji, S.K., Perrin, M.H, Sawaya, M.R., Jessberger, S., Vadodaria, K., Rissman, R.A., Singru, P. S., Nilsson, K.P.R., Simon, R., Schubert, D., Eisenberg, D., Rivier, J., Sawchenko, P., Vale, W. and Riek R. (2009) Functional amyloids as natural storage of peptide hormones in pituitary secretory granules. Science (on line).
[41]. [41]Klein WL, Stine WB, Teplow DB. Small assemblies of unmodified amyloid β-protein are the proximate neurotoxin in Alzheimer’s disease. Neurobiol. Aging. 2004;25:569–580. Abstract | Full Text |
Full-Text PDF (310 KB)
|
CrossRef
[42]. [42]Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science. 2002;297:353–356.
CrossRef
[43]. [43]Lazo ND, Maji SK, Fradinger EA, Bitan G, Teplow DB. The amyloid beta protein. In: Sipe JD editors. Amyloid Protein – The Beta Sheet Conformation and Disease. Weinheim, Germany: Wiley–VCH Publishers; 2005;p. 385–491.
[44]. [44]Chimon S, Shaibat MA, Jones CR, Calero DC, Aizezi B, Ishii Y. Evidence of fibril-like beta-sheet structures in a neurotoxic amyloid intermediate of Alzheimer’s beta-amyloid. Nat. Struct. Mol. Biol. 2007;14:1157–1164.
CrossRef
[45]. [45]Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science. 2003;300:486–489.
CrossRef
[46]. [46]Riek R. Cell biology: infectious Alzheimer’s disease?. Nature. 2006;444:429–431.
CrossRef
[47]. [47]Maji SK, Schubert D, Rivier C, Lee S, Rivier JE, Riek R. Amyloid as a depot for the formulation of long-acting drugs. PloS Biol. 2008;6:e17.
CrossRef
[48]. [48]Han HY, Weinreb PH, Lansbury PT. The core Alzheimer’s peptide Nac forms amyloid fibrils which seed and are seeded by β-Amyloid – is Nac a common trigger or target in neurodegenerative disease?. Chem. Biol. 1995;2:163–169. MEDLINE |
CrossRef
[49]. [49]Giasson BI, Forman MS, Higuchi M, Golbe LI, Graves CL, Kotzbauer PT, et al. Initiation and synergistic fibrillization of tau and alpha-synuclein. Science. 2003;300:636–640.
CrossRef
[50]. [50]Anfinsen CB. Principles that govern the folding of protein chains. Science. 1973;181:223–230. MEDLINE
[51]. [51]Ventura S, Villaverde A. Protein quality in bacterial inclusion bodies. Trends Biotechnol. 2006;24:179–185. MEDLINE |
CrossRef
[52]. [52]Wang L, Maji SK, Sawaya MR, Eisenberg D, Riek R. Bacterial inclusion bodies contain amyloid-like structure. PLoS Biol. 2008;6:e195.
CrossRef
[53]. [53]Guijarro JI, Sunde M, Jones JA, Campbell ID, Dobson CM. Amyloid fibril formation by an SH3 domain. Proc. Natl. Acad. Sci. USA. 1998;95:4224–4228. MEDLINE |
CrossRef
[54]. [54]Chiti F, Webster P, Taddei N, Clark A, Stefani M, Ramponi G, et al. Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc. Natl. Acad. Sci. USA. 1999;96:3590–3594. MEDLINE |
CrossRef
[55]. [55]Dobson CM. The structural basis of protein folding and its links with human disease. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2001;356:133–145. MEDLINE |
CrossRef
[56]. [56]Nelson R, Eisenberg D. Recent atomic models of amyloid fibril structure. Curr. Opin. Struct. Biol. 2006;16:260–265.
CrossRef
[57]. [57]Tjernberg L, Hosia W, Bark N, Thyberg J, Johansson J. Charge attraction and beta propensity are necessary for amyloid fibril formation from tetrapeptides. J. Biol. Chem. 2002;277:43243–43246. MEDLINE |
CrossRef
[58]. [58]Margittai M, Langen R. Side chain-dependent stacking modulates tau filament structure. J. Biol. Chem. 2006;281:37820–37827. MEDLINE |
CrossRef
[59]. [59]Zanuy D, Nussinov R. The sequence dependence of fiber organization. A comparative molecular dynamics study of the islet amyloid polypeptide segments 22–27 and 22–29. J. Mol. Biol. 2003;329:565–584. MEDLINE |
CrossRef
[60]. [60]Fernandez-Escamilla AM, Rousseau F, Schymkowitz J, Serrano L. Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat. Biotechnol. 2004;22:1302–1306. MEDLINE |
CrossRef
[61]. [61]Tartaglia GG, Pawar AP, Campioni S, Dobson CM, Chiti F, Vendruscolo M. Prediction of aggregation-prone regions in structured proteins. J. Mol. Biol. 2008;380:425–436.
CrossRef
[62]. [62]Polverino de Laureto P, Taddei N, Frare E, Capanni C, Costantini S, Zurdo J, et al. Protein aggregation and amyloid fibril formation by an SH3 domain probed by limited proteolysis. J. Mol. Biol. 2003;334:129–141. MEDLINE |
CrossRef
[63]. [63]Marcon G, Plakoutsi G, Canale C, Relini A, Taddei N, Dobson CM, et al. Amyloid formation from HypF-N under conditions in which the protein is initially in its native state. J. Mol. Biol. 2005;347:323–335. MEDLINE |
CrossRef
[64]. [64]Eisenberg D, Nelson R, Sawaya MR, Balbirnie M, Sambashivan S, Ivanova MI, et al. The structural biology of protein aggregation diseases: fundamental questions and some answers. Acc. Chem. Res. 2006;39:568–575. MEDLINE |
CrossRef
[65]. [65]Bennett MJ, Sawaya MR, Eisenberg D. Deposition diseases and 3D domain swapping. Structure. 2006;14:811–824. MEDLINE |
CrossRef
[66]. [66]Valéry C, Paternostre M, Robert B, Gulik-Krzywicki T, Narayanan T, Dedieu JC, et al. Biomimetic organization: octapeptide self-assembly into nanotubes of viral capsid-like dimension. Proc. Natl. Acad. Sci. USA. 2003;100:10258–10262. MEDLINE |
CrossRef
[67]. [67]Ryadnov MG. Peptide alpha-helices for synthetic nanostructures. Biochem. Soc. Trans. 2007;35:487–491. MEDLINE |
CrossRef
[68]. [68]Dvir H, Lundberg ME, Maji SK, Riek R, Choe S. Mistic: cellular localization, solution behavior, polymerization, and fibril formation. Protein Sci. 2009;18:1564–1570.
CrossRef
[69]. [69]Wiltzius JJ, Sievers SA, Sawaya MR, Cascio D, Popov D, Riekel C, et al. Atomic structure of the cross-beta spine of islet amyloid polypeptide (amylin). Protein Sci. 2008;17:1467–1474.
CrossRef
[70]. [70]Antzutkin ON, Leapman RD, Balbach JJ, Tycko R. Supramolecular structural constraints on Alzheimer’s beta-amyloid fibrils from electron microscopy and solid-state nuclear magnetic resonance. Biochemistry. 2002;41:15436–15450.
[71]. [71]Jaroniec CP, MacPhee CE, Astrof NS, Dobson CM, Griffin RG. Molecular conformation of a peptide fragment of transthyretin in an amyloid fibril. Proc. Natl. Acad. Sci. USA. 2002;99:16748–16753. MEDLINE |
CrossRef
[72]. [72]Petkova AT, Buntkowsky G, Dyda F, Leapman RD, Yau WM, Tycko R. Solid state NMR reveals a pH-dependent antiparallel beta-sheet registry in fibrils formed by a beta-amyloid peptide. J. Mol. Biol. 2004;335:247–260. MEDLINE |
CrossRef
[73]. [73]Kammerer RA, Kostrewa D, Zurdo J, Detken A, Garcia-Echeverria C, Green JD, et al. Exploring amyloid formation by a de novo design. Proc. Natl. Acad. Sci. USA. 2004;101:4435–4440. MEDLINE |
CrossRef
[74]. [74]Iwata K, Fujiwara T, Matsuki Y, Akutsu H, Takahashi S, Naiki H, et al. 3D structure of amyloid protofilaments of beta2-microglobulin fragment probed by solid-state NMR. Proc. Natl. Acad. Sci. USA. 2006;103:18119–18124. MEDLINE |
CrossRef
[75]. [75]Tycko R, Sciarretta KL, Orgel JP, Meredith SC. Evidence for novel-sheet structures in Iowa-mutant beta – amyloid fibrils. Biochemistry. 2009;48:6072–6084.
[76]. [76]Paravastu AK, Qahwash I, Leapman RD, Meredith SC, Tycko R. Seeded growth of {beta}-amyloid fibrils from Alzheimer’s brain-derived fibrils produces a distinct fibril structure. Proc. Natl. Acad. Sci. USA. 2009;106:7443–7448.
CrossRef
[77]. [77]Heise H, Hoyer W, Becker S, Andronesi OC, Riedel D, Baldus M. Molecular-level secondary structure, polymorphism, and dynamics of full-length alpha-synuclein fibrils studied by solid-state NMR. Proc. Natl. Acad. Sci. USA. 2005;102:15871–15876. MEDLINE |
CrossRef
[78]. [78]Baxa U, Wickner RB, Steven AC, Anderson DE, Marekov LN, Yau WM, et al. Characterization of beta-sheet structure in Ure2p1–89 yeast prion fibrils by solid-state nuclear magnetic resonance. Biochemistry. 2007;46:13149–13162.
[79]. [79]Chan JC, Oyler NA, Yau WM, Tycko R. Parallel beta-sheets and polar zippers in amyloid fibrils formed by residues 10–39 of the yeast prion protein Ure2p. Biochemistry. 2005;44:10669–10680.
[80]. [80]Luca S, Yau W, Leapman R, Tycko R. Peptide conformation and supramolecular organization in amylin fibrils: constraints from solid-state NMR. Biochemistry. 2007;46:13505–13522.
[81]. [81]Nielsen JT, Bjerring M, Jeppesen MD, Pedersen RO, Pedersen JM, Hein KL, et al. Unique identification of supramolecular structures in amyloid fibrils by solid-state NMR spectroscopy. Angew. Chem., Int. Ed. Engl. 2009;48:2118–2121.
CrossRef
[82]. [82]Madine J, Jack E, Stockley PG, Radford SE, Serpell LC, Middleton DA. Structural insights into the polymorphism of amyloid-like fibrils formed by region 20–29 of amylin revealed by solid-state NMR and X-ray fiber diffraction. J. Am. Chem. Soc. 2008;130:14990–15001.
CrossRef
[83]. [83]Shewmaker F, Wickner RB, Tycko R. Amyloid of the prion domain of Sup35p has an in-register parallel beta-sheet structure. Proc. Natl. Acad. Sci. USA. 2006;103:19754–19759. MEDLINE |
CrossRef
[84]. [84]Wickner RB, Dyda F, Tycko R. Amyloid of Rnq1p, the basis of the [PIN+] prion, has a parallel in-register beta-sheet structure. Proc. Natl. Acad. Sci. USA. 2008;105:2403–2408.
CrossRef
[85]. [85]Helmus JJ, Surewicz K, Nadaud PS, Surewicz WK, Jaroniec CP. Molecular conformation and dynamics of the Y145Stop variant of human prion protein in amyloid fibrils. Proc. Natl. Acad. Sci. USA. 2008;105:6284–6289.
CrossRef
[86]. [86]Laws DD, Bitter HML, Liu K, Ball HL, Kaneko K, Wille H, et al. Solid-state NMR studies of the secondary structure of a mutant prion protein fragment of 55 residues that induces neurodegeneration. Proc. Natl. Acad. Sci. USA. 2001;98:11686–11690. MEDLINE |
CrossRef
[87]. [87]Lim KH, Nguyen TN, Damo SM, Mazur T, Ball HL, Prusiner SB, et al. Solid-state NMR structural studies of the fibril form of a mutant mouse prion peptide PrP89–143(P101L). Solid State Nucl. Magn. Reson. 2006;29:183–190. MEDLINE |
CrossRef
[88]. [88]Kuwata K, Matumoto T, Cheng H, Nagayama K, James TL, Roder H. NMR-detected hydrogen exchange and molecular dynamics simulations provide structural insight into fibril formation of prion protein fragment 106–126. Proc. Natl. Acad. Sci. USA. 2003;100:14790–14795. MEDLINE |
CrossRef
[89]. [89]Ferguson N, Becker J, Tidow H, Tremmel S, Sharpe TD, Krause G, et al. General structural motifs of amyloid protofilaments. Proc. Natl. Acad. Sci. USA. 2006;103:16248–16253. MEDLINE |
CrossRef
[90]. [90]Olofsson A, Ippel JH, Wijmenga SS, Lundgren E, Ohman A. Probing solvent accessibility of transthyretin amyloid by solution NMR spectroscopy. J. Biol. Chem. 2004;279:5699–5707. MEDLINE |
CrossRef
[91]. [91]Olofsson A, Sauer-Eriksson AE, Ohman A. The solvent protection of alzheimer amyloid-beta-(1–42) fibrils as determined by solution NMR spectroscopy. J. Biol. Chem. 2006;281:477–483. MEDLINE |
CrossRef
[92]. [92]Olofsson A, Lindhagen-Persson M, Sauer-Eriksson AE, Ohman A. Amide solvent protection analysis demonstrates that amyloid-beta(1–40) and amyloid-beta(1–42) form different fibrillar structures under identical conditions. Biochem. J. 2007;404:63–70.
CrossRef
[93]. [93]Verel R, Tomka IT, Bertozzi C, Cadalbert R, Kammerer RA, Steinmetz MO, et al. Polymorphism in an amyloid-like fibril-forming model peptide. Angew. Chem., Int. Ed. Engl. 2008;47:5842–5845.
CrossRef
[94]. [94]Alexandrescu AT. An NMR-based quenched hydrogen exchange investigation of model amyloid fibrils formed by cold shock protein A. Pac. Symp. Biocomput. 2001;67–78.
[95]. [95]Ippel JH, Olofsson A, Schleucher J, Lundgren E, Wijmenga SS. Probing solvent accessibility of amyloid fibrils by solution NMR spectroscopy. Proc. Natl. Acad. Sci. USA. 2002;99:8648–8653. MEDLINE |
CrossRef
[96]. [96]Madine J, Copland A, Serpell LC, Middleton DA. Cross-beta spine architecture of fibrils formed by the amyloidogenic segment NFGSVQFV of medin from solid-state NMR and X-ray fiber diffraction measurements. Biochemistry. 2009;48:3089–3099.
[97]. [97]Lee SW, Mou Y, Lin SY, Chou FC, Tseng WH, Chen CH, et al. Steric zipper of the amyloid fibrils formed by residues 109–122 of the Syrian hamster prion protein. J. Mol. Biol. 2008;378:1142–1154.
CrossRef
[98]. [98]Wilson LM, Mok YF, Binger KJ, Griffin MD, Mertens HD, Lin F, et al. A structural core within apolipoprotein C-II amyloid fibrils identified using hydrogen exchange and proteolysis. J. Mol. Biol. 2007;366:1639–1651. MEDLINE |
CrossRef
[99]. [99]Bu Z, Shi Y, Callaway DJ, Tycko R. Molecular alignment within beta-sheets in Abeta(14–23) fibrils: solid-state NMR experiments and theoretical predictions. Biophys. J. 2007;92:594–602. MEDLINE |
CrossRef
[100]. [100]Whittemore NA, Mishra R, Kheterpal I, Williams AD, Wetzel R, Serpersu EH. Hydrogen-deuterium (H/D) exchange mapping of Abeta 1–40 amyloid fibril secondary structure using nuclear magnetic resonance spectroscopy. Biochemistry. 2005;44:4434–4441.
[101]. [101]Naito A, Kamihara M, Inoue R, Saitô H. Structural diversity of amyloid fibril formed in human calcitonin as revealed by site-directed 13C solid-state NMR spectroscopy. Magn. Reson. Chem. 2004;42:247–257. MEDLINE |
CrossRef